Breaking the Spell: Combating Multidrug Resistant ‘Superbugs’.
Front Microbiol. 2016 Feb 18;7:174.
Khan SN1, Khan AU1.
1Interdisciplinary Biotechnology Unit, Aligarh Muslim University Aligarh, India.
Multidrug-resistant (MDR) bacteria have become a severe threat to community wellbeing. Conventional antibiotics are getting progressively more ineffective as a consequence of resistance, making it imperative to realize improved antimicrobial options.
In this review we emphasized the microorganisms primarily reported of being resistance, referred as ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumanii, Pseudomonas aeruginosa, and Enterobacteriaceae) accentuating their capacity to “escape” from routine antimicrobial regimes.
The upcoming antimicrobial agents showing great potential and can serve as alternative therapeutic options are discussed.
We also provided succinct overview of two evolving technologies; specifically network pharmacology and functional genomics profiling.
Furthermore, In vivo imaging techniques can provide novel targets and a real time tool for potential lead molecule assessment.
The employment of such approaches at prelude of a drug development process, will enables more informed decisions on candidate drug selection and will maximize or predict therapeutic potential before clinical testing.
Entry filed under: Antimicrobianos, Bacterias, Bacteriemias, Biología Molecular, Epidemiología, Health Care-Associated Infections, Infecciones nosocomiales, Metodos diagnosticos, Resistencia bacteriana, REVIEWS, Sepsis, Update.